NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
63 hedge funds and large institutions have $19.9M invested in Nymox Pharmaceutical Corp in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+16
Holders Change %
+34.04%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
12
Reduced
11
Closed
8
Calls
$621K
Puts
$68K
Net Calls
+$553K
Net Calls Change
+$567K
Top Buyers
1 |
BlackRock
New York
|
+$6.2M |
2 |
State Street
Boston,
Massachusetts
|
+$1.5M |
3 |
Northern Trust
Chicago,
Illinois
|
+$1.45M |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$863K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$570K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.12M |
2 |
Millennium Management
New York
|
-$909K |
3 |
Goldman Sachs
New York
|
-$485K |
4 |
Renaissance Technologies
New York
|
-$161K |
5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$156K |